|
|
||||
|
Display of targets in multiple sclerosis
Email: Tudor Toma - t.toma@ic.ac.uk News from The Scientist 2002, 3(1):20020507-04
|
||||
|
|
||||
|
Multiple sclerosis (MS) is a central nervous system autoimmune disease but molecular mechanisms underlying the disorder remain largely unknown. In May Nature Medicine, Christopher Lock and colleagues from Stanford University, California, show that gene-microarray analysis of multiple sclerosis lesions has revealed potential new therapeutic targets (Nature Med 2002, 8:500-508).
|